R. Diskin, J. F. Scheid, P. M. Marcovecchio, A. P. West-jr, F. Klein et al., Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design, Science, vol.334, issue.6060, pp.1289-1293, 2011.
DOI : 10.1126/science.1213782

L. Ganesh, K. Leung, K. Loré, R. Levin, A. Panet et al., Infection of Specific Dendritic Cells by CCR5-Tropic Human Immunodeficiency Virus Type 1 Promotes Cell-Mediated Transmission of Virus Resistant to Broadly Neutralizing Antibodies, Journal of Virology, vol.78, issue.21, pp.11980-11987, 2004.
DOI : 10.1128/JVI.78.21.11980-11987.2004

I. S. Georgiev, N. A. Doria-rose, T. Zhou, Y. D. Kwon, R. P. Staupe et al., Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization, Science, vol.340, issue.6133, pp.751-756, 2013.
DOI : 10.1126/science.1233989

B. F. Haynes, P. B. Gilbert, M. J. Mcelrath, S. Zolla-pazner, G. D. Tomaras et al., Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial, New England Journal of Medicine, vol.366, issue.14, pp.1275-1286, 2012.
DOI : 10.1056/NEJMoa1113425

A. J. Hessell, P. Poignard, M. Hunter, L. Hangartner, D. M. Tehrani et al., Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques, Nature Medicine, vol.59, issue.8, pp.951-954, 1974.
DOI : 10.1038/nm.1974

L. Heyndrickx, A. Heath, E. Sheik-khalil, J. Alcami, V. Bongertz et al., International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II, PLoS ONE, vol.139, issue.5, p.36438, 2012.
DOI : 10.1371/journal.pone.0036438.s006

F. Klein, A. Halper-stromberg, J. A. Horwitz, H. Gruell, J. F. Scheid et al., HIV therapy by a combination of broadly neutralizing antibodies in humanized mice, Nature, vol.79, issue.7427, pp.118-122, 2012.
DOI : 10.1038/nature11604

P. D. Kwong and J. R. Mascola, Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies, Immunity, vol.37, issue.3, pp.412-425, 2012.
DOI : 10.1016/j.immuni.2012.08.012

URL : http://doi.org/10.1016/j.immuni.2012.08.012

A. Lepelley, S. Louis, M. Sourisseau, H. K. Law, J. Pothlichet et al., Innate Sensing of HIV-Infected Cells, PLoS Pathogens, vol.178, issue.2, p.1001284, 2011.
DOI : 10.1371/journal.ppat.1001284.s002

URL : https://hal.archives-ouvertes.fr/pasteur-00590930

H. X. Liao, R. Lynch, T. Zhou, F. Gao, S. M. Alam et al., Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus, Nature, vol.372, issue.7446, pp.469-476
DOI : 10.1038/nature12053

N. Martin, S. Welsch, C. Jolly, J. A. Briggs, D. Vaux et al., Virological Synapse-Mediated Spread of Human Immunodeficiency Virus Type 1 between T Cells Is Sensitive to Entry Inhibition, Journal of Virology, vol.84, issue.7, pp.3516-352702651, 2010.
DOI : 10.1128/JVI.02651-09

M. Massanella, I. Puigdomènech, C. Cabrera, M. T. Fernandez-figueras, A. Aucher et al., Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells, AIDS, vol.23, issue.2, pp.183-188, 2009.
DOI : 10.1097/QAD.0b013e32831ef1a3

L. E. Mccoy and R. A. Weiss, Neutralizing antibodies to HIV-1 induced by immunization, The Journal of Experimental Medicine, vol.72, issue.2, pp.209-223, 2013.
DOI : 10.1086/314452

B. Moldt, E. G. Rakasz, N. Schultz, P. Chan-hui, K. Swiderek et al., Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo, Proc. Natl. Acad. Sci. USA, pp.18921-18925, 2012.
DOI : 10.1073/pnas.1214785109

H. Mouquet, L. Scharf, Z. Euler, Y. Liu, C. Eden et al., Complex-type N-glycan recognition by potent broadly neutralizing Infection of humanized mice. HIV-1 infection of humanized mice, bNAb treatments, and analysis of viral loads and sequences were performed as described previously, Animal experiments were performed with authorization from the Institutional Review Board and the Institutional Animal Care and Use Committee at the Rockefeller University, 2012.

. Online and . Fig, S1 shows dose?response analysis of the antiviral effect of bNAb on cell-free and cell-associated infections. Fig. S2 shows that 10E8 treatment does not impose selective pressure on HIV-1 infection in humanized mice. Online supplemental material is available at http

I. A. Abela, L. Berlinger, M. Schanz, L. Reynell, H. F. Günthard et al., Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies, PLoS Pathogens, vol.79, issue.4, 2012.
DOI : 10.1371/journal.ppat.1002634.s006

A. B. Balazs, J. Chen, C. M. Hong, D. S. Rao, L. Yang et al., Antibody-based protection against HIV infection by vectored immunoprophylaxis, Nature, vol.188, issue.7379, pp.81-844688, 1038.
DOI : 10.1038/nature10660

D. R. Burton, R. Ahmed, D. H. Barouch, S. T. Butera, S. Crotty et al., A Blueprint for HIV Vaccine Discovery, Cell Host & Microbe, vol.12, issue.4, pp.396-407, 2012.
DOI : 10.1016/j.chom.2012.09.008

P. Chen, W. Hübner, M. A. Spinelli, and B. K. Chen, Predominant Mode of Human Immunodeficiency Virus Transfer between T Cells Is Mediated by Sustained Env-Dependent Neutralization-Resistant Virological Synapses, Journal of Virology, vol.81, issue.22, pp.12582-1259500381, 2007.
DOI : 10.1128/JVI.00381-07

B. M. Dale, R. A. Alvarez, and B. K. Chen, Mechanisms of enhanced HIV spread through T-cell virological synapses, Immunological Reviews, vol.29, issue.1, pp.113-124, 2013.
DOI : 10.1111/imr.12022

D. S. Dimitrov, R. L. Willey, H. Sato, L. J. Chang, R. Blumenthal et al., Quantitation of human immunodeficiency virus type 1 infection kinetics, J. Virol, vol.67, pp.2182-2190, 1993.

J. F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein et al., Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding, Science, vol.333, issue.6049, pp.1633-1637, 2011.
DOI : 10.1126/science.1207227

O. Schwartz, M. Alizon, J. M. Heard, and O. Danos, Impairment of T Cell Receptor-Dependent Stimulation in CD4+ Lymphocytes after Contact with Membrane-Bound HIV-1 Envelope Glycoprotein, Virology, vol.198, issue.1, pp.360-365, 1994.
DOI : 10.1006/viro.1994.1042

M. S. Seaman, H. Janes, N. Hawkins, L. E. Grandpre, C. Devoy et al., Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies, Journal of Virology, vol.84, issue.3, pp.1439-145202108, 2010.
DOI : 10.1128/JVI.02108-09

A. Sigal, J. T. Kim, A. B. Balazs, E. Dekel, A. Mayo et al., Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy, Nature, vol.31, issue.7362, pp.95-98, 2011.
DOI : 10.1038/nature10347

M. D. Simek, W. Rida, F. H. Priddy, P. Pung, E. Carrow et al., Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm, Journal of Virology, vol.83, issue.14, pp.7337-734800110, 2009.
DOI : 10.1128/JVI.00110-09

M. Sourisseau, N. Sol-foulon, F. Porrot, F. Blanchet, and O. Schwartz, Inefficient Human Immunodeficiency Virus Replication in Mobile Lymphocytes, Journal of Virology, vol.81, issue.2, pp.1000-101201629, 2007.
DOI : 10.1128/JVI.01629-06

URL : https://hal.archives-ouvertes.fr/pasteur-00292736

L. Stamatatos, L. Morris, D. R. Burton, and J. R. Mascola, Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?, Nature Medicine, vol.453, pp.866-870, 2009.
DOI : 10.1038/nm.1949

L. M. Walker, M. Huber, K. J. Doores, E. Falkowska, R. Pejchal et al., Broad neutralization coverage of HIV by multiple highly potent antibodies, Protocol G Principal Investigators, pp.466-470, 2011.
DOI : 10.1038/nature10373

A. P. West, R. Jr, M. C. Diskin, P. J. Nussenzweig, and . Bjorkman, Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120, Proc. Natl. Acad. Sci. USA, pp.2083-2090, 2012.
DOI : 10.1073/pnas.1208984109

X. Wu, T. Zhou, J. Zhu, B. Zhang, I. Georgiev et al., Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing, Science, vol.333, issue.6049, pp.1593-1602, 2011.
DOI : 10.1126/science.1207532

T. T. Murooka, M. Deruaz, F. Marangoni, V. D. Vrbanac, E. Seung et al., HIV-infected T cells are migratory vehicles for viral dissemination, Nature, vol.757, issue.7419, pp.283-2872715, 2012.
DOI : 10.1038/nature11398

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470742

J. Pietzsch, H. Gruell, S. Bournazos, B. M. Donovan, F. Klein et al., A mouse model for HIV-1 entry, Proc. Natl. Acad. Sci. USA, pp.15859-15864, 2012.
DOI : 10.1073/pnas.1213409109

I. Puigdomènech, N. Casartelli, F. Porrot, and O. Schwartz, SAMHD1 Restricts HIV-1 Cell-to-Cell Transmission and Limits Immune Detection in Monocyte-Derived Dendritic Cells, Journal of Virology, vol.87, issue.5, pp.2846-285602514, 2013.
DOI : 10.1128/JVI.02514-12

D. Rudnicka, J. Feldmann, F. Porrot, S. Wietgrefe, S. Guadagnini et al., Simultaneous Cell-to-Cell Transmission of Human Immunodeficiency Virus to Multiple Targets through Polysynapses, Journal of Virology, vol.83, issue.12, pp.6234-624600282, 2009.
DOI : 10.1128/JVI.00282-09

URL : https://hal.archives-ouvertes.fr/pasteur-00458065

J. F. Salazar-gonzalez, M. G. Salazar, B. F. Keele, G. H. Learn, E. E. Giorgi et al., Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection, The Journal of Experimental Medicine, vol.79, issue.6, pp.1273-1289, 2009.
DOI : 10.1128/JVI.79.16.10108-10125.2005

D. N. Sather, J. Armann, L. K. Ching, A. Mavrantoni, G. Sellhorn et al., Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.83, issue.2, pp.757-76902036, 2009.
DOI : 10.1128/JVI.02036-08

Q. J. Sattentau, The direct passage of animal viruses between cells, Current Opinion in Virology, vol.1, issue.5, pp.396-402, 2011.
DOI : 10.1016/j.coviro.2011.09.004

J. F. Scheid, H. Mouquet, N. Feldhahn, M. S. Seaman, K. Velinzon et al., Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals, Nature, vol.301, issue.7238, pp.636-640, 2009.
DOI : 10.1038/nature07930